Erwin De Cock

2PUBLICATIONS
7CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Feb 14, 2026
Time and Motion Study to Quantify Time for Tysabri (Natalizumab) Intravenous Versus Subcutaneous to Treat Relapsing-Remitting Multiple Sclerosis in France, Spain, and the United Kingdom.

Erwin De Cock, Khalil Jomaa, Jyothi Menon

|Oct 20, 2025
A Time and Motion Study Comparing Subcutaneous Pembrolizumab Versus Intravenous Pembrolizumab in Combination with Chemotherapy for the Treatment of Metastatic Non-small Cell Lung Cancer.

Erwin De Cock, Sabine Oskar, Cecilia Lourdudoss

Pageof 1

Frequent Collaborators

1 joint publications

Sabine Oskar

1 joint publications

Cecilia Lourdudoss

1 joint publications

Renata Eiras

1 joint publications

M Catherine Pietanza